Caprion Wins US $13.1M Biodefense Research Contract

Caprion Pharmaceuticals Inc. has been awarded a US $13.1 million contract by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, to carry out biodefense research. This award is the result of a highly competitive and international selection process.

Back to news